Prevalence of Increased FDG PET/CT Axillary Lymph Node Uptake Beyond 6 Weeks after mRNA COVID-19 Vaccination
Yael Eshet, Noam Tau, Yousef Alhoubani, Nayroz Kanana, Liran Domachevsky, Michal Eifer
Abstract
Ipsilateral avid axillary lymph node uptake at FDG PET/CT persists in 29% (49 of 169) of patients between 7 to 10 weeks after the second dose of the mRNA-based BNT162b2 COVID-19 vaccination.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Vaccination2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Lymph nodePositron Emission Tomography-Computed TomographyRadiologyPET-CTAxillary lymph nodesNuclear medicinePositron emission tomographyPathologyInternal medicineMetastasisCancerDiseaseInfectious disease (medical specialty)OutbreakLymphadenopathy Diagnosis and AnalysisLymphoma Diagnosis and TreatmentColorectal and Anal Carcinomas